ALNY

Alnylam Pharmaceuticals, Inc.

1 day chart

About ALNY

Alnylam Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in developing therapeutics based on ribonucleic acid interference (RNAi). Its pipeline includes five marketed products and over ten clinical programs, including several in late-stage development, across four strategic therapeutic areas (STArs): genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and CNS/ocular diseases. Its RNAi-based medicines include ONPATTRO (patisiran), AMVUTTRA (vutrisiran), GIVLAARI (givosiran), OXLUMO (lumasiran) and Leqvio (inclisiran). ONPATTRO is an intravenously administered RNAi therapeutic targeting transthyretin amyloidosis. GIVLAARI is used to reduce induced liver aminolevulinic acid synthase 1 messenger RNA (mRNA), to reduce toxins associated with attacks and other disease manifestations of acute hepatic porphyria. OXLUMO is an RNAi therapeutic targeting hydroxyacid oxidase 1 for the treatment of primary hyperoxaluria type 1.

Buy US stocks in Australia starting with ALNY. Open an account and start investing today!

Market Capitalisation

$24.22B

Price-earnings ratio

Dividend yield

0.00%

Volume

102.01K

High today

$198.93

Low today

$195.50

Open price

$195.50

52-week high

$242.97

52-week low

$117.58

ALNY FAQs

How much is one share of Alnylam Pharmaceuticals, Inc.?

One share of Alnylam Pharmaceuticals, Inc. is valued at $198.05.

What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?

The ticker symbol for Alnylam Pharmaceuticals, Inc. is ALNY.

How do I buy ALNY shares in Australia?

To buy ALNY stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in ALNY

What is the 52-week high for Alnylam Pharmaceuticals, Inc. stock?

The Alnylam Pharmaceuticals, Inc. 52-week high stock price is $242.97.

What is the 52-week low for Alnylam Pharmaceuticals, Inc. stock?

The Alnylam Pharmaceuticals, Inc. 52-week low stock price is $117.58.

What is the market capitalisation of Alnylam Pharmaceuticals, Inc. ALNY?

As of 31/03/2023 Alnylam Pharmaceuticals, Inc. has a market cap of $24B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.